Search research articles
Contact Us
Filters
Showing results (811-820 of 832) with videos related to
Page
of 84
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2015
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
Nabil Ahmed, Vita S Brawley, Meenakshi Hegde, et al.
Breast (Edinburgh, Scotland)
|
October 21, 2022
Influence of age as a continuous variable on the prognosis of patients with pT1-2N1 breast cancer
Xu-Ran Zhao, Yu Tang, Hong-Fen Wu, et al.
Radiation Oncology (London, England)
|
November 29, 2023
Quality assurance in a phase III, multicenter, randomized trial of POstmastectomy radioThErapy in Node posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a planning benchmark case
Yu-Chun Song, Zhi-Hui Hu, Xue-Na Yan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2023
Dose-Volume Predictors for Radiation Esophagitis in Patients With Breast Cancer Undergoing Hypofractionated Regional Nodal Radiation Therapy
Dan-Qiong Wang, Na Zhang, Li-Hua Dong, et al.
Cancer Science
|
December 25, 2018
E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemness
Frank H C Cheng, Hon-Yi Lin, Tzy-Wei Hwang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 24, 2020
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma
Carlos A Ramos, Natalie S Grover, Anne W Beaven, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 8, 2025
Prospective cohort study to validate esophageal dose constraints and predictive models for esophagitis in patients with breast cancer undergoing hypofractionated regional nodal radiotherapy
Dan-Qiong Wang, Lei Yan, Hong-Fen Wu, et al.
Oncotarget
|
December 3, 2014
DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study
Hon-Yi Lin, Shih-Kai Hung, Moon-Sing Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 10, 2018
High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease
Asaf D Yanir, Imelda C Hanson, William T Shearer, et al.
JAMA Oncology
|
April 21, 2017
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial
Nabil Ahmed, Vita Brawley, Meenakshi Hegde, et al.
Page
of 84
Search research articles
Search
Showing results (811-820 of 832) with videos related to
Sort By:
Page
of 84
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2015
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
Nabil Ahmed, Vita S Brawley, Meenakshi Hegde, et al.
Breast (Edinburgh, Scotland)
|
October 21, 2022
Influence of age as a continuous variable on the prognosis of patients with pT1-2N1 breast cancer
Xu-Ran Zhao, Yu Tang, Hong-Fen Wu, et al.
Radiation Oncology (London, England)
|
November 29, 2023
Quality assurance in a phase III, multicenter, randomized trial of POstmastectomy radioThErapy in Node posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a planning benchmark case
Yu-Chun Song, Zhi-Hui Hu, Xue-Na Yan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2023
Dose-Volume Predictors for Radiation Esophagitis in Patients With Breast Cancer Undergoing Hypofractionated Regional Nodal Radiation Therapy
Dan-Qiong Wang, Na Zhang, Li-Hua Dong, et al.
Cancer Science
|
December 25, 2018
E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemness
Frank H C Cheng, Hon-Yi Lin, Tzy-Wei Hwang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 24, 2020
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma
Carlos A Ramos, Natalie S Grover, Anne W Beaven, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 8, 2025
Prospective cohort study to validate esophageal dose constraints and predictive models for esophagitis in patients with breast cancer undergoing hypofractionated regional nodal radiotherapy
Dan-Qiong Wang, Lei Yan, Hong-Fen Wu, et al.
Oncotarget
|
December 3, 2014
DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study
Hon-Yi Lin, Shih-Kai Hung, Moon-Sing Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 10, 2018
High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease
Asaf D Yanir, Imelda C Hanson, William T Shearer, et al.
JAMA Oncology
|
April 21, 2017
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial
Nabil Ahmed, Vita Brawley, Meenakshi Hegde, et al.
Page
of 84